Inhibition of Rac Family Protein Impairs Colitis and Colitis-associated Cancer in Mice

Overview

Journal Am J Cancer Res

Specialty Oncology

Date 2018 Feb 9

PMID 29416921

Citations 5

Authors

Yandong Guo

Jing Xiong

Jing Wang

Jing Wen

Fachao Zhi

Affiliations

Soon will be listed here.

Abstract

The prevalence of inflammatory bowel disease (IBD) has increased worldwide and IBD has been demonstrated to promote the development of colorectal cancer. The Rac family of proteins are involved in key mitogenic pathways. However, to the best of our knowledge, no prior studies have investigated the expression and role of Rac on colitis and colitis-associated cancer (CAC). In the current study, Rac expression in patients with colitis was analyzed according to the expression value from NCBI GEO database (GDS3268). EHT-1864, the specific inhibitor of Rac, was intraperitoneally injected to treat mice with dextran sulfate sodium (DSS)-induced acute and chronic colitis and mice with azoxymethane (AOM)/DSS-induced CAC. Furthermore, immune cell infiltration and the expression of several inflammatory cytokines in colon tissues were analyzed by flow cytometry, immunofluorescence, and ELISAs. We demonstrated the upregulation of the Rac family of proteins in colitis. Inhibition of Rac by EHT-1864 treatment was found to have an efficient inhibitory effect on DSS-induced acute and chronic colitis and AOM/DSS-induced CAC development. We also observed that downregulation of Rac family protein expression markedly prevented macrophage and myeloid-derived suppressor cell (MDSC) infiltration in colon tissues and suppressed pro-inflammatory cytokine expression. Our study established a foundation for understanding the role of Rac in colitis and CAC and to provide a novel strategy and target for colitis and CAC therapy.

Citing Articles

Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation.

van Geffen C, Heiss C, Deissler A, Kolahian S Front Immunol. 2022; 13:933847.

PMID: 36110844 PMC: 9468781. DOI: 10.3389/fimmu.2022.933847.

Epithelial RAC1-dependent cytoskeleton dynamics controls cell mechanics, cell shedding and barrier integrity in intestinal inflammation.

Martinez-Sanchez L, Ngo P, Pradhan R, Becker L, Boehringer D, Soteriou D Gut. 2022; 72(2):275-294.

PMID: 35241625 PMC: 9872254. DOI: 10.1136/gutjnl-2021-325520.

Rho GTPases as Key Molecular Players within Intestinal Mucosa and GI Diseases.

Pradhan R, Ngo P, Martinez-Sanchez L, Neurath M, Lopez-Posadas R Cells. 2021; 10(1).

PMID: 33406731 PMC: 7823293. DOI: 10.3390/cells10010066.

Characterization of a Novel Diarrheagenic Strain of Associated With Food Poisoning in China.

Gong Z, Shi X, Bai F, He X, Zhang H, Li Y Front Microbiol. 2020; 10:2810.

PMID: 31921012 PMC: 6921692. DOI: 10.3389/fmicb.2019.02810.

Post-transcriptional Gene Regulation in Colitis Associated Cancer.

Chen G, Feng Y, Li X, Jiang Z, Bei B, Zhang L Front Genet. 2019; 10:585.

PMID: 31275360 PMC: 6593052. DOI: 10.3389/fgene.2019.00585.

References

Steinbach E, Plevy S . The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis. 2013; 20(1):166-75. PMC: 4098861. DOI: 10.1097/MIB.0b013e3182a69dca. View

Bosco E, Kumar S, Marchioni F, Biesiada J, Kordos M, Szczur K . Rational design of small molecule inhibitors targeting the Rac GTPase-p67(phox) signaling axis in inflammation. Chem Biol. 2012; 19(2):228-42. PMC: 3292765. DOI: 10.1016/j.chembiol.2011.12.017. View

Wang Y, Kunit T, Ciotkowska A, Rutz B, Schreiber A, Strittmatter F . Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864. Br J Pharmacol. 2015; 172(11):2905-17. PMC: 4439884. DOI: 10.1111/bph.13099. View

Satpathy S, Jala V, Bodduluri S, Krishnan E, Hegde B, Hoyle G . Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth. Nat Commun. 2015; 6:7064. PMC: 4418220. DOI: 10.1038/ncomms8064. View

Prantera C, Pallone F, Brunetti G, Cottone M, Miglioli M . Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. Gastroenterology. 1992; 103(2):363-8. DOI: 10.1016/0016-5085(92)90822-g. View

Rosenblatt A, Garcia M, Lyons L, Xie Y, Maiorino C, Desire L . Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer. Endocr Relat Cancer. 2010; 18(2):207-19. PMC: 3644524. DOI: 10.1677/ERC-10-0049. View

Bruckner M, Lenz P, Mucke M, Gohar F, Willeke P, Domagk D . Diagnostic imaging advances in murine models of colitis. World J Gastroenterol. 2016; 22(3):996-1007. PMC: 4716050. DOI: 10.3748/wjg.v22.i3.996. View

Sands B . The risks and benefits of early immunosuppression and biological therapy. Dig Dis. 2013; 30 Suppl 3:100-6. DOI: 10.1159/000342731. View

Dooley J, Abdel-Latif D, St Laurent C, Puttagunta L, Befus D, Lacy P . Regulation of inflammation by Rac2 in immune complex-mediated acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2009; 297(6):L1091-102. PMC: 2793190. DOI: 10.1152/ajplung.90471.2008. View

10.

Trivedi P, Bruns T, Ward S, Mai M, Schmidt C, Hirschfield G . Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity. J Autoimmun. 2016; 68:98-104. PMC: 4803021. DOI: 10.1016/j.jaut.2016.01.001. View

11.

Wang F, Johnson R, Snyder P, DeSmet M, Fleet J . An Inducible, Large-Intestine-Specific Transgenic Mouse Model for Colitis and Colitis-Induced Colon Cancer Research. Dig Dis Sci. 2015; 61(4):1069-79. PMC: 5476293. DOI: 10.1007/s10620-015-3971-7. View

12.

Weigmann B, Tubbe I, Seidel D, Nicolaev A, Becker C, Neurath M . Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc. 2007; 2(10):2307-11. DOI: 10.1038/nprot.2007.315. View

13.

Yang J, Xu L . Elevated IL-23R Expression and Foxp3+Rorgt+ Cells in Intestinal Mucosa During Acute and Chronic Colitis. Med Sci Monit. 2016; 22:2785-92. PMC: 4988365. DOI: 10.12659/msm.896827. View

14.

Kamada N, Hisamatsu T, Okamoto S, Sato T, Matsuoka K, Arai K . Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol. 2005; 175(10):6900-8. DOI: 10.4049/jimmunol.175.10.6900. View

15.

Pan D, Amison R, Riffo-Vasquez Y, Spina D, Cleary S, Wakelam M . P-Rex and Vav Rac-GEFs in platelets control leukocyte recruitment to sites of inflammation. Blood. 2014; 125(7):1146-58. PMC: 4326774. DOI: 10.1182/blood-2014-07-591040. View

16.

Bromberg J, Wang T . Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell. 2009; 15(2):79-80. PMC: 3684978. DOI: 10.1016/j.ccr.2009.01.009. View

17.

Gillen C, Walmsley R, Prior P, Andrews H, Allan R . Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994; 35(11):1590-2. PMC: 1375617. DOI: 10.1136/gut.35.11.1590. View

18.

Prantera C, Marconi S . Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity. Therap Adv Gastroenterol. 2013; 6(2):137-56. PMC: 3589135. DOI: 10.1177/1756283X12473675. View

19.

Cooks T, Pateras I, Tarcic O, Solomon H, Schetter A, Wilder S . Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell. 2013; 23(5):634-46. PMC: 3657134. DOI: 10.1016/j.ccr.2013.03.022. View

20.

Dai L, Cui X, Zhang X, Cheng L, Liu Y, Yang Y . SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin. Nat Commun. 2016; 7:11996. PMC: 4931276. DOI: 10.1038/ncomms11996. View